A nationwide prospective cohort study on safety of the 17D-204 yellow fever vaccine during a vaccine shortage in Japan

In response to the vaccine shortage of yellow fever vaccine (YF-VAX) due to manufacturing delays, the unapproved 17D-204 YF-VAX was used as an investigator-initiated clinical trial in Japan. The vaccine was administered to 11 279 participants in 19 YF vaccination centres in Japan, and few serious ad...

Descripción completa

Detalles Bibliográficos
Autores principales: Miyazato, Yusuke, Terada, Mari, Ujiie, Mugen, Saito, Sho, Moriya, Akinari, Ando, Masao, Ohmagari, Norio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10075058/
https://www.ncbi.nlm.nih.gov/pubmed/35640301
http://dx.doi.org/10.1093/jtm/taac070

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10075058/
https://www.ncbi.nlm.nih.gov/pubmed/35640301
http://dx.doi.org/10.1093/jtm/taac070

Ejemplares similares